scispace - formally typeset
R

Ratna Sari Wijaya

Researcher at University of Pelita Harapan

Publications -  14
Citations -  177

Ratna Sari Wijaya is an academic researcher from University of Pelita Harapan. The author has contributed to research in topics: Vaccination & Medicine. The author has an hindex of 5, co-authored 9 publications receiving 78 citations. Previous affiliations of Ratna Sari Wijaya include University of Sydney.

Papers
More filters
Journal ArticleDOI

Macrophage Coordination of the Interferon Lambda Immune Response.

TL;DR: It is demonstrated that macrophages are primary responders to IFN-λ, uniquely positioned to bridge the gap between IFn-λ producing cells and lymphocyte populations that are not intrinsically responsive to IFE, highlighting a novel role for macrophage in shaping IFN -λ dependent immune responses.
Journal ArticleDOI

KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B.

TL;DR: It is demonstrated that these specific NK cells are able to kill activated stellate cells in the liver, and may provide a novel therapeutic approach to treat liver fibrosis in patients with CHB.
Journal ArticleDOI

HBV vaccination and HBV infection induces HBV-specific natural killer cell memory

TL;DR: The data support the presence of a mature mNKs following HBV antigen exposure either through vaccination or infection, and provides an opportunity to develop novel treatments targeting HBV in chronic infection.
Journal ArticleDOI

Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia.

TL;DR: In this article, the authors investigated the magnitude and durability of antibodies against the spike (S) protein (anti-S) in fully-vaccinated HCWs using an electrochemiluminescence immunoassay.
Journal ArticleDOI

Post-vaccination cases of COVID-19 among healthcare workers at Siloam Teaching Hospital, Indonesia.

TL;DR: In this article, the authors identified cases of COVID-19 among vaccinated HCWs at Siloam Teaching Hospital, Indonesia via active and passive surveillance conducted by the hospital's COVID19 infection prevention and control unit.